VF
IRWD icon

Virtu Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Virtu Financial’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,960
Closed -$60K – 1916
2026
Q1 		$60K Buy
+16,960
New +$69.5K ﹤0.01% 1259
2024
Q4 		– Sell
-18,962
Closed -$78K – 1782
2024
Q3 		$78K Buy
+18,962
New +$102K ﹤0.01% 944
2023
Q2 		– Sell
-11,722
Closed -$123K – 1756
2023
Q1 		$123K Buy
+11,722
New +$131K 0.01% 911
2022
Q3 		– Sell
-10,707
Closed -$123K – 1957
2022
Q2 		$123K Buy
+10,707
New +$126K 0.01% 893
2021
Q1 		– Sell
-17,141
Closed -$195K – 1807
2020
Q4 		$195K Buy
+17,141
New +$188K 0.02% 872
2019
Q4 		$147K Sell
11,067
-5,888
-35% -$64.9K 0.01% 1011
2019
Q3 		$146K Buy
+16,955
New +$165K 0.01% 1026

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Virtu Financial's IRWD Position: Q2 2026 in Review

Virtu Financial sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2026, closing a stake of 16,960 shares — an estimated $60K sold.

Virtu Financial first reported a position in IRWD in Q3 2019 and held it in 7 quarters. The position peaked at $195K in Q4 2020. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Virtu Financial reported no remaining Ironwood Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 16,960 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $60K.
  • Virtu Financial first reported a position in Ironwood Pharmaceuticals in Q3 2019 and held it in 7 quarters.
  • Virtu Financial's Ironwood Pharmaceuticals position peaked at $195K in Q4 2020.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.